Medical PET equipment and related products

Secretin (33-59), rat (TFA) is a 27-aa peptide, which acts on secretin receptor , and enhances the secretion of bicarbonate, enzymes, and K + from the pancreas.Appearance:SolidIC50&amp: Target:Secretin receptorBiological Activity:Secretin (33-59),

Secretin (33-59), rat (TFA) is a 27-aa peptide, which acts on secretin receptor , and enhances the secretion of bicarbonate, enzymes, and K + from the pancreas.Appearance:SolidIC50&amp: Target:Secretin receptorBiological Activity:Secretin (33-59),

PI3K-IN-36 (compound A36) is a potent PI3K inhibitor. PI3K-IN-36 can be used in research of follicular lymphoma (FL).Form:Solid.

PI3K-IN-36 (compound A36) is a potent PI3K inhibitor. PI3K-IN-36 can be used in research of follicular lymphoma (FL).Form:Solid.

PI3K-IN-36 (compound A36) is a potent PI3K inhibitor. PI3K-IN-36 can be used in research of follicular lymphoma (FL).Form:Solid.

PTP1B-IN-3 is a potent and orally active PTP1B inhibitor with IC 50 s of 120 nM for both PTP1B and TCPTP. PTP1B-IN-3 has antidiabetic and anticancer effectsIn VivoIn diet-induced obese (DIO) mice, PTP1B-IN-3 (compounds 3g) exhibits dose dependent

PTP1B-IN-3 is a potent and orally active PTP1B inhibitor with IC 50 s of 120 nM for both PTP1B and TCPTP. PTP1B-IN-3 has antidiabetic and anticancer effectsIn VivoIn diet-induced obese (DIO) mice, PTP1B-IN-3 (compounds 3g) exhibits dose dependent

PTP1B-IN-3 is a potent and orally active PTP1B inhibitor with IC 50 s of 120 nM for both PTP1B and TCPTP. PTP1B-IN-3 has antidiabetic and anticancer effectsIn VivoIn diet-induced obese (DIO) mice, PTP1B-IN-3 (compounds 3g) exhibits dose dependent

Nampt-IN-10 TFA (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 TFA shows cellular potency to A2780 and CORL23 cells lines with IC 50 s of 5 and 19 nM, respectively. Nampt-IN-10 TFA can be used as a novel

Nampt-IN-10 TFA (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 TFA shows cellular potency to A2780 and CORL23 cells lines with IC 50 s of 5 and 19 nM, respectively. Nampt-IN-10 TFA can be used as a novel

Nampt-IN-10 TFA (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 TFA shows cellular potency to A2780 and CORL23 cells lines with IC 50 s of 5 and 19 nM, respectively. Nampt-IN-10 TFA can be used as a novel

Nampt-IN-10 TFA (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 TFA shows cellular potency to A2780 and CORL23 cells lines with IC 50 s of 5 and 19 nM, respectively. Nampt-IN-10 TFA can be used as a novel